Screener
Actinium Pharmaceuticals ATNM Q3 2025 earnings
Reported November 14, 2025 · Before market open
Revenue$90.0KBeat by $22.5K
EPS-$0.16Beat by $0.09
Revenue estimate$67.5K
EPS estimate-$0.25
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$1.2M
EPS estimate-$0.25
Versus estimates
Revenue
Q2 2026$35.0MIn line
Q3 2025$90.0KBeat by $22.5K
Diluted EPS
FAQ
- When did Actinium Pharmaceuticals report Q3 2025 earnings?
- Actinium Pharmaceuticals (ATNM) reported Q3 2025 earnings on November 14, 2025 before market open.
- What were Actinium Pharmaceuticals's Q3 2025 revenue and EPS?
- Actinium Pharmaceuticals reported revenue of $90.0K and eps of $-0.16 for Q3 2025.
- Did Actinium Pharmaceuticals beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $67.5K by $22.5K. EPS beat the consensus estimate of $-0.25 by $0.09.
- How did Actinium Pharmaceuticals's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 56.8% from $-0.37.
- Where can I find Actinium Pharmaceuticals's Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001213900-25-110979) directly on SEC EDGAR. The filing index links above go to sec.gov.
